• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺血性中风/短暂性脑缺血发作后的长期预后。

Long-term outcome after ischaemic stroke/transient ischaemic attack.

作者信息

Hankey Graeme J

机构信息

Stroke Unit, Royal Perth Hospital and Department of Medicine, University of Western Australia, Perth, WA, Australia.

出版信息

Cerebrovasc Dis. 2003;16 Suppl 1:14-9. doi: 10.1159/000069936.

DOI:10.1159/000069936
PMID:12698014
Abstract

During the first 30 days after a stroke, the case fatality is about 25% and the major cause of death is the index stroke and its sequelae. The most consistent predictor of 30-day mortality after stroke is stroke severity. Other predictors include increasing age, a history of previous stroke, cardiac failure, and a high blood glucose concentration and white blood cell count. Other less common, but important, causes of early mortality are recurrent ischaemic stroke and a coronary event. The risk of a recurrent cerebrovascular event is highest in the first month (4%) and year (12%) after a stroke and transient ischaemic attack (TIA), probably reflecting the presence of active, unstable atherosclerotic plaque. Thereafter, the risk of a recurrent cerebrovascular event falls to about 5% per year, similar to the risk of a coronary event. During years 1-5 after a TIA and ischaemic stroke, cardiovascular disease increasingly becomes the major cause of death, reflecting the generalized nature of atherothrombosis, the most common cause of the index stroke. The most robust predictor of death within 1-5 years after stroke is increasing age, closely followed by cardiac failure. Additional baseline predictors of longer-term mortality include a history of previous symptomatic atherothrombosis (TIA, ischaemic stroke, peripheral arterial disease, and early-onset ischaemic heart disease), risk factors for atherothrombosis (smoking), other heart diseases (cardiac failure, atrial fibrillation) and increasing stroke severity. Lacunar syndromes can be predictive of relative longevity. At 5 years after stroke, survival is about 40%, and about half of survivors are disabled and dependent. The most robust predictors of disability at 5 years after stroke are increasing age, stroke severity, and recurrent stroke. The most powerful predictor of early recurrent stroke (within 30 days after stroke) is an atherosclerotic ischaemic stroke caused by large-artery atherosclerosis with >50% stenosis, whereas the strongest predictor of stroke recurrence over 5 years is diabetes. Other predictors of recurrent stroke include increasing age, previous TIA, atrial fibrillation, high alcohol consumption, haemorrhagic index stroke, and hypertension at discharge. The clinical implication of these findings is that strategies for optimizing long-term outcome after TIA and stroke should be directed toward reducing the high risk of recurrent stroke and coronary events by removing/recanalizing the symptomatic atherosclerotic plaque, controlling the underlying causal vascular risk factors, and administering long-term, effective antiplatelet therapy.

摘要

在中风后的头30天内,病死率约为25%,主要死亡原因是首发中风及其后遗症。中风后30天死亡率最一致的预测因素是中风严重程度。其他预测因素包括年龄增长、既往中风史、心力衰竭、高血糖浓度和白细胞计数。早期死亡的其他不太常见但重要的原因是复发性缺血性中风和冠状动脉事件。中风和短暂性脑缺血发作(TIA)后的第一个月(4%)和第一年(12%),复发性脑血管事件的风险最高,这可能反映了活跃、不稳定的动脉粥样硬化斑块的存在。此后,复发性脑血管事件的风险降至每年约5%,与冠状动脉事件的风险相似。在TIA和缺血性中风后的1至5年里,心血管疾病越来越成为主要死亡原因,这反映了动脉粥样硬化血栓形成的普遍性,而动脉粥样硬化血栓形成是首发中风最常见的原因。中风后1至5年内死亡最有力的预测因素是年龄增长,紧随其后的是心力衰竭。长期死亡率的其他基线预测因素包括既往有症状性动脉粥样硬化血栓形成史(TIA、缺血性中风、外周动脉疾病和早发性缺血性心脏病)、动脉粥样硬化血栓形成的危险因素(吸烟)、其他心脏病(心力衰竭、心房颤动)以及中风严重程度增加。腔隙综合征可预测相对较长的寿命。中风后5年,生存率约为40%,约一半的幸存者有残疾且需要依赖他人。中风后5年残疾最有力的预测因素是年龄增长、中风严重程度和复发性中风。中风后早期复发(中风后30天内)最有力的预测因素是由大动脉粥样硬化导致的狭窄>50%的动脉粥样硬化缺血性中风,而中风复发超过5年的最强预测因素是糖尿病。复发性中风的其他预测因素包括年龄增长、既往TIA、心房颤动、大量饮酒、出血性首发中风以及出院时的高血压。这些发现的临床意义在于,优化TIA和中风后长期预后的策略应旨在通过清除/再通有症状的动脉粥样硬化斑块、控制潜在的因果血管危险因素以及给予长期有效的抗血小板治疗来降低复发性中风和冠状动脉事件的高风险。

相似文献

1
Long-term outcome after ischaemic stroke/transient ischaemic attack.缺血性中风/短暂性脑缺血发作后的长期预后。
Cerebrovasc Dis. 2003;16 Suppl 1:14-9. doi: 10.1159/000069936.
2
Risk of subsequent disabling or fatal stroke in patients with transient ischaemic attack or minor ischaemic stroke: an international, prospective cohort study.短暂性脑缺血发作或小卒中患者随后发生致残性或致死性卒中的风险:一项国际前瞻性队列研究。
Lancet Neurol. 2022 Oct;21(10):889-898. doi: 10.1016/S1474-4422(22)00302-7.
3
Major vascular events after transient ischaemic attack and minor ischaemic stroke: post hoc modelling of incidence dynamics.短暂性脑缺血发作和轻度缺血性卒中后的主要血管事件:发病动态的事后建模
Cerebrovasc Dis. 2008;25(3):225-33. doi: 10.1159/000113860. Epub 2008 Jan 24.
4
Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study.短暂性脑缺血发作或轻度缺血性卒中后的长期生存及血管事件风险:一项队列研究
Lancet. 2005;365(9477):2098-104. doi: 10.1016/S0140-6736(05)66734-7.
5
Diagnosis of non-consensus transient ischaemic attacks with focal, negative, and non-progressive symptoms: population-based validation by investigation and prognosis.以调查和预后为基础的人群验证:对具有局灶性、负向和非进行性症状的非共识性短暂性脑缺血发作的诊断。
Lancet. 2021 Mar 6;397(10277):902-912. doi: 10.1016/S0140-6736(20)31961-9.
6
Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study.隐源性短暂性脑缺血发作和缺血性卒中的发病率、结局、危险因素及长期预后:一项基于人群的研究。
Lancet Neurol. 2015 Sep;14(9):903-913. doi: 10.1016/S1474-4422(15)00132-5. Epub 2015 Jul 27.
7
The Alberta Stroke Prevention in TIAs and mild strokes (ASPIRE) intervention: rationale and design for evaluating the implementation of a province-wide TIA triaging system.阿尔伯塔短暂性脑缺血发作和轻度中风预防(ASPIRE)干预措施:评估全省范围内短暂性脑缺血发作分诊系统实施情况的基本原理与设计
Int J Stroke. 2014 Oct;9 Suppl A100:135-43. doi: 10.1111/j.1747-4949.2012.00881.x. Epub 2012 Oct 23.
8
Periodontal Disease Associated with Aortic Arch Atheroma in Patients with Stroke or Transient Ischemic Attack.中风或短暂性脑缺血发作患者中与主动脉弓粥样硬化相关的牙周疾病
J Stroke Cerebrovasc Dis. 2017 Oct;26(10):2137-2144. doi: 10.1016/j.jstrokecerebrovasdis.2017.04.035. Epub 2017 May 24.
9
Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.抗血小板治疗预防复发性卒中及其他严重血管事件:临床试验数据与指南综述
Curr Med Res Opin. 2007 Jun;23(6):1453-62. doi: 10.1185/030079907X199727. Epub 2007 May 17.
10
Management of atherothrombosis with clopidogrel in high-risk patients with recent transient ischaemic attack or ischaemic stroke (MATCH): study design and baseline data.近期发生短暂性脑缺血发作或缺血性卒中的高危患者使用氯吡格雷治疗动脉粥样硬化血栓形成(MATCH):研究设计与基线数据
Cerebrovasc Dis. 2004;17(2-3):253-61. doi: 10.1159/000076962. Epub 2004 Feb 23.

引用本文的文献

1
Powered knee exoskeleton improves sit-to-stand transitions in stroke patients using electromyographic control.电动膝关节外骨骼通过肌电图控制改善中风患者从坐立转换的能力。
Commun Eng. 2025 Jun 7;4(1):104. doi: 10.1038/s44172-025-00440-3.
2
Chronic Administration with FAD012 (3,5-Dimethyl-4-hydroxycinnamic Acid) Maintains Cerebral Blood Flow and Ameliorates Swallowing Dysfunction After Chronic Cerebral Hypoperfusion in Rats.FAD012(3,5-二甲基-4-羟基肉桂酸)长期给药可维持大鼠慢性脑灌注不足后的脑血流量并改善吞咽功能障碍。
Int J Mol Sci. 2025 Apr 1;26(7):3277. doi: 10.3390/ijms26073277.
3
Safety and Efficacy of Stem Cell Therapy in Ischemic Stroke: A Comprehensive Systematic Review and Meta-Analysis.
干细胞疗法治疗缺血性中风的安全性与有效性:一项全面的系统评价与荟萃分析
J Clin Med. 2025 Mar 20;14(6):2118. doi: 10.3390/jcm14062118.
4
Impact of Microglia-Derived Extracellular Vesicles on Resident Central Nervous System Cell Populations After Acute Brain Injury Under Various External Stimuli Conditions.不同外部刺激条件下,小胶质细胞衍生的细胞外囊泡对急性脑损伤后中枢神经系统常驻细胞群体的影响。
Mol Neurobiol. 2025 Mar 24. doi: 10.1007/s12035-025-04858-w.
5
Sex Differences in Trends in Stroke Recurrence and Postrecurrence Mortality 2000-2020: Population-Based Brain Attack Surveillance in Corpus Christi Project.2000-2020 年卒中复发和复发后死亡率的性别差异:科珀斯克里斯蒂项目的基于人群的脑卒中专案监测。
Ann Neurol. 2024 Aug;96(2):332-342. doi: 10.1002/ana.26955. Epub 2024 May 17.
6
Transitioning to home and beyond following stroke: a prospective cohort study of outcomes and needs.脑卒中后居家及转归的前瞻性队列研究:结局与需求评估
BMC Health Serv Res. 2024 Apr 10;24(1):449. doi: 10.1186/s12913-024-10820-8.
7
Long-Term Functional Outcome in Patients With Isolated Thalamic Stroke: The KOSCO Study.孤立性丘脑卒中患者的长期功能转归:KOSCO研究
J Am Heart Assoc. 2024 Feb 20;13(4):e032377. doi: 10.1161/JAHA.123.032377. Epub 2024 Feb 13.
8
The Predictive Value of Essen and SPI-II on the Risk of 5-Year Recurrence in Chinese Patients with Acute Ischemic Stroke.Essen评分和SPI-II评分对中国急性缺血性脑卒中患者5年复发风险的预测价值
Neuropsychiatr Dis Treat. 2023 Oct 24;19:2251-2260. doi: 10.2147/NDT.S433383. eCollection 2023.
9
Self-reported life-space mobility in the first year after ischemic stroke: longitudinal findings from the MOBITEC-Stroke project.缺血性脑卒中后第一年的自我报告生活空间移动能力:MOBITEC-Stroke 项目的纵向研究结果。
J Neurol. 2023 Aug;270(8):3992-4003. doi: 10.1007/s00415-023-11748-5. Epub 2023 May 4.
10
High prevalence of abdominal aortic aneurysm in older men with cerebrovascular disease: Evaluation of a local screening program.老年脑血管疾病男性患者腹主动脉瘤的高患病率:一项本地筛查项目的评估
Front Neurol. 2023 Apr 11;14:1131322. doi: 10.3389/fneur.2023.1131322. eCollection 2023.